ANN ARBOR, Mich.–(BUSINESS WIRE)–RetroSense Therapeutics Chief Executive Officer Sean Ainsworth will present at the 27th Annual Piper Jaffray Healthcare Conference and the Genetic RX Conference.
ACADIA Pharmaceuticals Appoints Srdjan (Serge) Stankovic, M.D., M.S.P.H., as Executive Vice President, Head of Research and Development
SAN DIEGO–(BUSINESS WIRE)–ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system (CNS) disorders, today…
ACADIA Pharmaceuticals Appoints Edmund P. Harrigan, M.D., to Board of Directors
SAN DIEGO–(BUSINESS WIRE)–ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system (CNS) disorders, today…
Uncategorized
VIDEO: Shire emerges in areas of unmet need in ophthalmology
LAS VEGAS — At the American Academy of Ophthalmology annual meeting, Shire CEO Flemming Ornskov, MD, MPH, discusses the company’s plans for progress and innovation in the ophthalmic industry.
When Doctors Get Sick: Three Stories of Addiction
(MedPage Today) — Different paths to the bottom and back up
Uncategorized
VIDEO: Surgeon discusses learning curve of residents using femtosecond-assisted technology for cataract surgery
LAS VEGAS — At the American Academy of Ophthalmology annual meeting, Wallace Chamon, MD, discusses the learning curve of residents using the Catalys platform (Abbott Medical Optics) for femtosecond-assisted cataract surgery.